Long-term treatment with the combination of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: outcomes during the open label …

JW Eikelboom, J Bosch, SJ Connolly… - European Heart …, 2022 - academic.oup.com
Aims To describe outcomes of patients with chronic coronary artery disease (CAD) and/or
peripheral artery disease (PAD) enrolled in the Cardiovascular Outcomes for People Using …
被引用次数：17 相关文章

Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open …

JW Eikelboom, J Bosch, SJ Connolly, J Tyrwitt… - European heart journal …, 2022 - vbn.aau.dk
AIMS: To describe outcomes of patients with chronic coronary artery disease (CAD) and/or
peripheral artery disease (PAD) enrolled in the Cardiovascular Outcomes for People Using …

Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open …

JW Eikelboom, J Bosch, SJ Connolly… - European heart …, 2022 - research.regionh.dk
AIMS: To describe outcomes of patients with chronic coronary artery disease (CAD) and/or
peripheral artery disease (PAD) enrolled in the Cardiovascular Outcomes for People Using …
[PDF] academia.edu

[PDF][PDF] Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the …

JW Eikelboom, J Bosch, SJ Connolly, J Tyrwitt… - 2022 - academia.edu
Aims: To describe outcomes of patients with chronic coronary artery disease (CAD) and/or
peripheral artery disease (PAD) enrolled in The Cardiovascular Outcomes for People Using …

Long-term treatment with the combination of rivaroxaban and aspirin in patients with chronic coronary or peripheral artery disease: outcomes during the open label …

JW Eikelboom, J Bosch, SJ Connolly, J Tyrwitt… - European Heart …, 2022 - ruj.uj.edu.pl
Long-term treatment with the combination of rivaroxaban and aspirin in patients with chronic
coronary or peripheral artery disease : outcomes during the open label extension of the …

Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open …

JW Eikelboom, J Bosch, SJ Connolly… - European Heart …, 2022 - lirias.kuleuven.be
Aims: To describe outcomes of patients with chronic coronary artery disease (CAD) and/or
peripheral artery disease (PAD) enrolled in The Cardiovascular Outcomes for People Using …

Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open …

JW Eikelboom, J Bosch, SJ Connolly, J Tyrwitt… - 2022 - pubmed.ncbi.nlm.nih.gov
Aims To describe outcomes of patients with chronic coronary artery disease (CAD) and/or
peripheral artery disease (PAD) enrolled in the Cardiovascular Outcomes for People Using …

Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open …

JW Eikelboom, J Bosch, SJ Connolly… - European Heart …, 2022 - academic.oup.com
Aims To describe outcomes of patients with chronic coronary artery disease (CAD) and/or
peripheral artery disease (PAD) enrolled in the Cardiovascular Outcomes for People Using …

Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open …

JW Eikelboom, J Bosch, SJ Connolly… - European Heart …, 2022 - europepmc.org
Aims To describe outcomes of patients with chronic coronary artery disease (CAD) and/or
peripheral artery disease (PAD) enrolled in the Cardiovascular Outcomes for People Using …

Long-Term Treatment with the Combination of Rivaroxaban and Aspirin in Patients with Chronic Coronary or Peripheral Artery Disease: Outcomes During the Open …

J Eikelboom, J Bosch, S Connolly… - European Heart …, 2022 - unilim.hal.science
Aims To describe outcomes of patients with chronic coronary artery disease (CAD) and/or
peripheral artery disease (PAD) enrolled in The Cardiovascular Outcomes for People Using …